No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Tuesday, May 12, 2026
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Medicare

That Discount at the Pharmacy Counter May Pack Hidden Costs

by TheAdviserMagazine
5 days ago
in Medicare
Reading Time: 5 mins read
A A
That Discount at the Pharmacy Counter May Pack Hidden Costs
Share on FacebookShare on TwitterShare on LInkedIn


Next time you go to the pharmacy, you might be offered a coupon on your prescription drugs. While it may sound like a great deal — with the prospect of saving hundreds of dollars — the decision to accept it is complicated, especially for people with insurance.

Even as prescription drug costs rise, patients with commercial insurance have slowed their use of manufacturer-sponsored drug coupons in recent years, according to a study published April 6 by the Journal of the American Medical Association.

Manufacturers are offering just as many of them, “but still, we see a lot of affordability issues among this commercially insured population,” said So-Yeon Kang, the study’s main author, who is an assistant professor of health management and policy at Georgetown University.

“Patients are at the intersection and battle place between these payers and manufacturers,” she said.

Drug manufacturers distribute copay coupon cards to consumers online or in person at the pharmacy counter. These manufacturer-sponsored coupons are not the same as discount card services from companies like GoodRx, which negotiate lower bulk pricing for prescription drugs, then pass those savings along to the consumer.

Manufacturers issue the coupons to keep their drugs competitive by offering patients short-term savings. Consumers pay less out-of-pocket, often for brand-name drugs. This encourages patients to use the brand-name version of the drug, even when a cheaper, generic version might be available.

Some insurers say this unfairly puts them on the hook for pricier drugs. They say monthly premiums are higher as a result, punishing consumers and patients, not the manufacturers.

So, should you use manufacturer-sponsored prescription drug coupons when they are offered?

The short answer: It depends.

Email Sign-Up

Subscribe to KFF Health News’ free Morning Briefing.

Here are five things to consider:

1. What if you do not have insurance?

If you are uninsured, using a coupon can be a great way to save money, especially if there is no generic version of the drug.

TrumpRx is a new federally funded initiative that acts as a prescription drug coupon dashboard for patients. Some of the coupons come from manufacturers, while others do not. Not every drug has a coupon offer, but the portal will save consumers money on drugs for those that do, especially in the short term.

Michelle Long, a senior policy manager at KFF who studies patient and consumer protections, said people without insurance can save money by using TrumpRx or manufacturer coupons. (KFF is the health policy research, polling, and news organization that includes KFF Health News.)

“I wouldn’t brush it off entirely because it’s got Trump’s name on it,” Long said. “For a lot of people who take certain medications, there really could be some real savings.”

Still, Long said, TrumpRx lists only about 85 drugs, among thousands approved by the FDA. It is important to note that drug coupons have limitations and guidelines. They do not last forever. When they are exhausted, uninsured consumers may have to pay full price for the drug.

2. What if you have commercial health insurance?

For people with insurance, the answer is a little more complicated.

If the drug isn’t covered by your insurance plan or if you intend to pay cash, then the coupon may be the way to go. If not, be wary.

Insurance coverage varies for certain kinds of drugs, such as GLP-1 obesity drugs. Kang’s study found that coupon use by commercial insurance holders on obesity drugs dropped from 54.6% of prescriptions in 2017 to only 2.5% in 2024, even though use of the drugs has been rising in the United States.

She said this reflects the growing number of patients paying cash for the drugs as prices decline, along with insurers’ reluctance to cover them and manufacturers’ shifting focus from coupon distribution to marketing campaigns.

3. What should you do if you expect high medical costs this year?

If you have insurance and anticipate meeting your deductible for the year through health care visits and treatments, consider using the coupons.

Coupons let you pay less out-of-pocket when you visit the pharmacy, but your insurer likely won’t count the value of the coupon toward your deductible. Only use a coupon if there is no generic option available and if you know you’d otherwise hit your deductible.

4. What if you have insurance but low overall medical costs?

The answer will almost always be: Don’t use the coupon.

Unless the drug you are looking for is not covered by your insurance plan, using coupons will put you at risk for higher indirect costs. It’s also often more advantageous to spend toward your deductible.

Watch out for copay adjustment programs that insurers use to discourage the use of drug coupons. They come in two common forms, Long said.

“Copay accumulators” allow the use of drug coupons up to their full value, but the amount of the coupon won’t count toward patients’ deductibles or out-of-pocket maximums. That makes it harder for them to reach the threshold at which insurers will pitch in on prescriptions and other medical care. It can also mean a patient will eventually start paying the full cost of the drug because they haven’t yet met their annual deductible.

“Copay maximizers” use a similar technique that also prevents the coupon value from counting toward deductibles. Maximizer programs use a third party to adjust patients’ copayments over the course of a year to match the amount of the manufacturers’ coupons.

Insurers sometimes offer the programs to consumers under euphemistic names like “Employee Savings Program” that sound good in theory, but, in reality, take away some of the value of the coupons, Long said.

Initially, consumers will see savings at the pharmacy counter, but they may end up paying more in the long run.

5. What if you’re on Medicaid or Medicare?

Medicare and Medicaid beneficiaries are prohibited from using manufacturer-sponsored coupons.

A federal anti-kickback law makes it illegal to give someone anything of value to influence their decision to purchase something that will ultimately be paid for by a federal health care program. The law also prevents remuneration, which includes waiving copays and charging less than fair-market value for a product.

Manufacturer drug coupons squarely fit within both categories.

Some states, notably California and Massachusetts, prohibit or limit the use of manufacturer drug coupons when a generic version of the drug is available — highlighting the tension among manufacturers, health plans, and the government.



Source link

Tags: CostsCounterDiscountHiddenpackPharmacy
ShareTweetShare
Previous Post

Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.

Next Post

8 Stocks Yet to Join the Rally With Upside Potential of Up to 85%

Related Posts

edit post
In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.

In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.

by TheAdviserMagazine
May 8, 2026
0

When Gavin Newsom ran for California governor in 2018, his support for a state-run single-payer healthcare system was considered a...

edit post
Abortion Pill Politics – KFF Health News

Abortion Pill Politics – KFF Health News

by TheAdviserMagazine
May 7, 2026
0

The Host A decision Friday night by a federal appeals court not only has raised new questions about the continued...

edit post
Understanding depression to get the right care

Understanding depression to get the right care

by TheAdviserMagazine
May 7, 2026
0

In our busy lives, it can be hard to find some quiet time to check in and ask yourself how...

edit post
Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.

Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.

by TheAdviserMagazine
May 7, 2026
0

Since his second term started, President Donald Trump has announced, negotiated, or floated a flurry of initiatives aimed at taming...

edit post
Boosting brain health 

Boosting brain health 

by TheAdviserMagazine
May 6, 2026
0

This month’s edition of Healthy You! reminds employees that taking care of their brain is just as important as taking care of...

edit post
Gavin Newsom, Early Champion of Single-Payer, Moderates in the Face of Fiscal Limits

Gavin Newsom, Early Champion of Single-Payer, Moderates in the Face of Fiscal Limits

by TheAdviserMagazine
May 1, 2026
0

SACRAMENTO, Calif. — In his earliest days in the governor’s office, Democrat Gavin Newsom huddled with his advisers to consider...

Next Post
edit post
8 Stocks Yet to Join the Rally With Upside Potential of Up to 85%

8 Stocks Yet to Join the Rally With Upside Potential of Up to 85%

edit post
Philip Morris – PM: Rauchfreie Zukunft mit IQOS statt Marlboro!

Philip Morris – PM: Rauchfreie Zukunft mit IQOS statt Marlboro!

  • Trending
  • Comments
  • Latest
edit post
Gavin Newsom issues ‘final warning’ amid California’s dire housing crisis — what’s at stake for millions of residents

Gavin Newsom issues ‘final warning’ amid California’s dire housing crisis — what’s at stake for millions of residents

May 3, 2026
edit post
Florida Warning: With Senior SNAP Benefits Averaging 8/Month, Thousands Risk Losing Assistance in 2026

Florida Warning: With Senior SNAP Benefits Averaging $188/Month, Thousands Risk Losing Assistance in 2026

April 27, 2026
edit post
Minnesota Wealth Tax | Intangible Personal Property Tax

Minnesota Wealth Tax | Intangible Personal Property Tax

May 6, 2026
edit post
10 Cheapest High Dividend Stocks With P/E Ratios Under 10

10 Cheapest High Dividend Stocks With P/E Ratios Under 10

April 13, 2026
edit post
Exclusive: America’s largest Black-owned bank launches podcast with mission to unlock hidden shame holding back generational wealth

Exclusive: America’s largest Black-owned bank launches podcast with mission to unlock hidden shame holding back generational wealth

April 29, 2026
edit post
NYC Mayor Mamdani knocked Ken Griffin in pied-a-terre tax promo. His firm calls the move ‘shameful’

NYC Mayor Mamdani knocked Ken Griffin in pied-a-terre tax promo. His firm calls the move ‘shameful’

April 23, 2026
edit post
Putin’s Misleading Factoids on Russia-Israel Ties

Putin’s Misleading Factoids on Russia-Israel Ties

0
edit post
Hackers Targeting Your Crypto Just Got An AI Upgrade — Google’s Report Is A Wake-Up Call

Hackers Targeting Your Crypto Just Got An AI Upgrade — Google’s Report Is A Wake-Up Call

0
edit post
Fiscal deficit falls to lowest since 2023

Fiscal deficit falls to lowest since 2023

0
edit post
9 Scientists Connected To The U.S. Space Program Are Dead As Speculation Grows That The U.S. Government Is In Contact With Aliens

9 Scientists Connected To The U.S. Space Program Are Dead As Speculation Grows That The U.S. Government Is In Contact With Aliens

0
edit post
A wildfire burning in the Everglades near Broward/Miami-Dade County line has grown to 5k acres and remains 0% contained as it approaches US-27

A wildfire burning in the Everglades near Broward/Miami-Dade County line has grown to 5k acres and remains 0% contained as it approaches US-27

0
edit post
Gold and silver prices today, Monday, May 11: Gold and silver down this morning after Trump rejects Iran’s peace plan

Gold and silver prices today, Monday, May 11: Gold and silver down this morning after Trump rejects Iran’s peace plan

0
edit post
Hackers Targeting Your Crypto Just Got An AI Upgrade — Google’s Report Is A Wake-Up Call

Hackers Targeting Your Crypto Just Got An AI Upgrade — Google’s Report Is A Wake-Up Call

May 12, 2026
edit post
Clarity Act: US Senate Banking Committee Releases Draft Crypto Market Structure Bill

Clarity Act: US Senate Banking Committee Releases Draft Crypto Market Structure Bill

May 12, 2026
edit post
Exagen reaffirms M-M 2026 revenue guidance as it targets 0-0 ASP over time (NASDAQ:XGN)

Exagen reaffirms $70M-$73M 2026 revenue guidance as it targets $600-$650 ASP over time (NASDAQ:XGN)

May 12, 2026
edit post
One MobiKwik Systems Q4 Results: Co swings to black with Rs 4 crore profit vs Rs 56 crore loss YoY

One MobiKwik Systems Q4 Results: Co swings to black with Rs 4 crore profit vs Rs 56 crore loss YoY

May 12, 2026
edit post
US Real Estate Remains Stale

US Real Estate Remains Stale

May 12, 2026
edit post
Conversations with Frank Fabozzi, CFA, Featuring Sue Brake

Conversations with Frank Fabozzi, CFA, Featuring Sue Brake

May 11, 2026
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Hackers Targeting Your Crypto Just Got An AI Upgrade — Google’s Report Is A Wake-Up Call
  • Clarity Act: US Senate Banking Committee Releases Draft Crypto Market Structure Bill
  • Exagen reaffirms $70M-$73M 2026 revenue guidance as it targets $600-$650 ASP over time (NASDAQ:XGN)
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.